Page last updated: 2024-08-24

rutecarpine and Androgen-Independent Prostatic Cancer

rutecarpine has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
He, J; Huang, C; Huang, H; Jiang, L; Liao, Y; Liu, J; Liu, Y; Shao, Z; Tang, D; Xia, X	1

Other Studies

1 other study(ies) available for rutecarpine and Androgen-Independent Prostatic Cancer

Article	Year
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy. Theranostics, 2020, Volume: 10, Issue:8 Topics: Alkaloids; Androgen Receptor Antagonists; Animals; Antineoplastic Agents, Phytogenic; Castration; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Nuclear Proteins; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Proteolysis; Receptors, Androgen; Ubiquitin-Protein Ligases; Ubiquitination; Xenograft Model Antitumor Assays	2020

Article

Year

Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy.

Theranostics, 2020, Volume: 10, Issue:8

Topics: Alkaloids; Androgen Receptor Antagonists; Animals; Antineoplastic Agents, Phytogenic; Castration; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Heat-Shock Proteins; HEK293 Cells; Humans; Male; Mice; Mice, Inbred BALB C; Nuclear Proteins; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Proteolysis; Receptors, Androgen; Ubiquitin-Protein Ligases; Ubiquitination; Xenograft Model Antitumor Assays

2020